Schedule 13D ownership disclosure

AERIE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00771V108

Event date: 2014-11-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,087,466
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-14-000622
Form type
SC 13D/A
Filer
AERIE PHARMACEUTICALS INC
CIK
CIK 1337553
Filed
Nov 26, 2014
Reporting period
Nov 25, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub